EFPIA - NEWSLETTER

EFPIA Newsletter 26 September 2024

Establishing criteria for unmet medical needs: let’s not leave people living with chronic diseases behind

By Johan Luthman, Executive Vice President, Lundbeck

The narrow definition of unmet medical need used in the General Pharmaceutical Legislation may hinder rather than help efforts to find new treatments.

In the world of medicine development, innovation is closely associated with unmet needs. When we as a pharmaceutical company advance innovative science into development, we take a holistic perspective on the unmet need – for instance, new biology, patient and caregiver preferences, a gap in current treatment options, better safety profile and value to society.

News

26 September 2024 EFPIA position on opt-out in the EHDS Regulation

EFPIA stresses the importance of avoiding fragmentation and bias, clarifying the scope of the opt-out by limiting it...

Rethinking Alzheimer’s Disease Pathway: From Diagnosis to Care

On the occasion of World Alzheimer's month, EBC and EFPIA are launching the paper "Rethinking Alzheimer's Disease Pathway: From Diagnosis to Care." This new report is a call to action to adopt forward-thinking policies, rethink existing models, and pioneer new approaches to reduce the impact of Alzheimer's and improve the lives of millions.

Read the full report here.

Vaccines Europe 2023 annual report is now available!

VE 2023 annual report focuses on the work done across the vaccine ecosystem towards realising the full value of vaccination.

Read the full report here.

Events

27 SEP 2024

Why tackling chronic disease is a priority for Europe: Restating the case for investing... Hybrid event - Bad Hofgastein, Austria

As Europe faces demographic, economic, and geopolitical challenges that make it difficult to increase health budgets,...

Learn more →

What we are reading

Building a future-proof regulatory system 26 September 2024 (POLITICO)

The world is facing an antibiotic emergency: a data-led plan of action is needed now 24 September 2024 (The Guardian)

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence... 19 September 2024 (Find For Rare)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶